WAM
NVRO

Wealthspire Advisors (Maryland)’s NEVRO CORP. NVRO Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$13K – 2135
2019
Q1 		$13K Buy
+200
New +$9.4K ﹤0.01% 1436

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s NVRO Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 200 shares — an estimated $13K sold.

Wealthspire Advisors (Maryland) first reported a position in NVRO in Q1 2019 and held it in 1 quarter. The position peaked at $13K in Q1 2019. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 200 NEVRO CORP. shares in Q2 2019, an estimated $13K.
  • Wealthspire Advisors (Maryland) first reported a position in NEVRO CORP. in Q1 2019 and held it in 1 quarter.
  • Wealthspire Advisors (Maryland)'s NEVRO CORP. position peaked at $13K in Q1 2019.
  • 162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.